Skip to main content
. 2012 Feb 13;47(10):1312–1317. doi: 10.1038/bmt.2012.1

Figure 1.

Figure 1

Probabilities of OS and PFS for patients undergoing myeloablative or non-myeloablative allogeneic hematopoietic cell transplants. First line: OS of 134 patients undergoing nonmyeloabaltive allografting; Second line: PFS of 134 patients undergoing non-myeloabaltive allografting; Third line: OS of 144 patients undergoing myeloablative allografting; Fourth line: PFS of 144 patients undergoing myeloablative allografting.